Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy

Leptin Does Not Mediate Hypertension Associated With Human Obesity

(2015) Rebecca J. Brown et al.   CELL

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

(2015) Talia Diker-Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lymphoma in acquired generalized lipodystrophy

(2015) Rebecca J. Brown et al.   LEUKEMIA & LYMPHOMA

Leptin in congenital and HIV-associated lipodystrophy

(2015) Michael A. Tsoukas et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Leptin treatment: Facts and expectations

(2015) Gilberto Paz-Filho et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin on metabolic and hepatic endpoints

(2014) Alexander J. Rodríguez et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Leptin Mediates the Increase in Blood Pressure Associated with Obesity

(2014) Stephanie E. Simonds et al.   CELL

Bone Mineral Content in Patients With Congenital Generalized Lipodystrophy Is Unaffected by Metreleptin Replacement Therapy

(2014) John D. Christensen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lipid Regulation in Lipodystrophy Versus the Obesity-Associated Metabolic Syndrome: The Dissociation of HDL-C and Triglycerides

(2014) Jalaja Joseph et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Targeting APOC3 in the Familial Chylomicronemia Syndrome

(2014) Daniel Gaudet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease

(2014) F. Payne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals

(2013) Hyun-Seuk Moon et al.   ENDOCRINE REVIEWS

Metreleptin Improves Blood Glucose in Patients With Insulin Receptor Mutations

(2013) Rebecca J. Brown et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The liver diseases of lipodystrophy: The long-term effect of leptin treatment

(2013) Elika Safar Zadeh et al.   JOURNAL OF HEPATOLOGY

Leptin in the Liver: A Toxic or Beneficial Mix?

(2012) Marc L. Reitman   Cell Metabolism

Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling

(2012) Kento Imajo et al.   Cell Metabolism

Pregnancy in a Woman With Congenital Generalized Lipodystrophy

(2012) Marcy Maguire et al.   OBSTETRICS AND GYNECOLOGY

Lipodystrophies: Genetic and Acquired Body Fat Disorders

(2011) Abhimanyu Garg   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin Resistance Is a Sufficient Basis for Hyperandrogenism in Lipodystrophic Women with Polycystic Ovarian Syndrome

(2011) Andreea O. Lungu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Is there a human model for the ‘metabolic syndrome’ with a defined aetiology?

(2010) P. Gorden et al.   DIABETOLOGIA

A historical perspective on leptin

(2010) Douglas L Coleman   NATURE MEDICINE

Leptin therapy in insulin-deficient type I diabetes

(2010) M.-y. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leptin in humans: lessons from translational research

(2009) Susann Blüher et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Efficacy of leptin therapy in the different forms of human lipodystrophy

(2009) A. Y. Chong et al.   DIABETOLOGIA